Clinical trial
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular…
NCT00001764 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001764 |
|---|---|
| Title | Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions |
| Official title | Mycophenolate Mofetil in the Treatment of Wegener's Granulomatosis and Related Vasculitides |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Vasculitis, Wegener's Granulomatosis |
| Intervention type | Drug |
| Interventions | Mycophenolate Mofetil |
| Enrollment | 50 |
| Start date | Apr 1, 1998 |
| Completion | Jun 1, 2004 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: